Widespread use of the atypical antipsychotic quetiapine has resulted in the increased possibility of its interaction with other concurrently administered psychotropic agents. For example, the antiepileptic lamotrigine, commonly prescribed for the management of bipolar disorder, has a potential drug-drug interaction with co-administered quetiapine..
{"title":"Lamotrigine and quetiapine interaction","authors":"Y. W. Francis Lam Pharm.D., FCCP","doi":"10.1002/pu.31154","DOIUrl":"https://doi.org/10.1002/pu.31154","url":null,"abstract":"<p>Widespread use of the atypical antipsychotic quetiapine has resulted in the increased possibility of its interaction with other concurrently administered psychotropic agents. For example, the antiepileptic lamotrigine, commonly prescribed for the management of bipolar disorder, has a potential drug-drug interaction with co-administered quetiapine..</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140329064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Survey finds new users of psychedelics report unusual visual experiences","authors":"","doi":"10.1002/pu.31148","DOIUrl":"https://doi.org/10.1002/pu.31148","url":null,"abstract":"","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140031806","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A population-based study conducted in Taiwan has found that use of benzodiazepines during pregnancy increases risk of miscarriage. This increased risk persisted in analyses that were adjusted for multiple confounding variables, the investigators reported. Results were published online Dec. 27, 2023, in JAMA Psychiatry.
{"title":"Benzodiazepine use in pregnancy linked to higher risk of miscarriage","authors":"","doi":"10.1002/pu.31140","DOIUrl":"https://doi.org/10.1002/pu.31140","url":null,"abstract":"<p>A population-based study conducted in Taiwan has found that use of benzodiazepines during pregnancy increases risk of miscarriage. This increased risk persisted in analyses that were adjusted for multiple confounding variables, the investigators reported. Results were published online Dec. 27, 2023, in <i>JAMA Psychiatry</i>.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140031907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A single 25-mg dose of psilocybin resulted in improvement in depressive symptoms in all 15 participants in an open-label nonrandomized trial enrolling adults with bipolar II disorder. Twelve of the 15 participants met response and remission criteria at the study's 12-week endpoint.
{"title":"Patients with bipolar II disorder benefit from single dose of psilocybin","authors":"","doi":"10.1002/pu.31143","DOIUrl":"https://doi.org/10.1002/pu.31143","url":null,"abstract":"<p>A single 25-mg dose of psilocybin resulted in improvement in depressive symptoms in all 15 participants in an open-label nonrandomized trial enrolling adults with bipolar II disorder. Twelve of the 15 participants met response and remission criteria at the study's 12-week endpoint.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140031910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Study finds semaglutide not associated with higher risk of suicidality","authors":"","doi":"10.1002/pu.31149","DOIUrl":"https://doi.org/10.1002/pu.31149","url":null,"abstract":"","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140031807","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Pimavanserin reduced risk of relapse to psychosis in Parkinson's dementia","authors":"","doi":"10.1002/pu.31150","DOIUrl":"https://doi.org/10.1002/pu.31150","url":null,"abstract":"","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140031808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Synthetic glucocorticoids, such as dexamethasone and prednisolone, are commonly used in the treatment of patients with inflammatory conditions and autoimmune disorders. However, the multiple physiological effects that glucocorticoids exert can often result in short- and long-term adverse drug reactions, including neuropsychiatric adverse events. Despite the widespread use of glucocorticoids, the prevalence of neuropsychiatric adverse events with these medications, while believed to be common, has not been rigorously quantified.
{"title":"Neuropsychiatric effects of glucocorticoids","authors":"Y. W. Francis Lam Pharm.D., FCCP","doi":"10.1002/pu.31141","DOIUrl":"https://doi.org/10.1002/pu.31141","url":null,"abstract":"<p>Synthetic glucocorticoids, such as dexamethasone and prednisolone, are commonly used in the treatment of patients with inflammatory conditions and autoimmune disorders. However, the multiple physiological effects that glucocorticoids exert can often result in short- and long-term adverse drug reactions, including neuropsychiatric adverse events. Despite the widespread use of glucocorticoids, the prevalence of neuropsychiatric adverse events with these medications, while believed to be common, has not been rigorously quantified.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140031908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A comparative effectiveness study using a U.S. commercial insurance database has found small increases in risk of mortality and other adverse outcomes when benzodiazepine treatment is discontinued in long-term users. Mortality risk was higher in subgroups of discontinuers both with and without exposure to opioids.
{"title":"Discontinuation of benzodiazepines after long-term use increases mortality risk","authors":"","doi":"10.1002/pu.31142","DOIUrl":"https://doi.org/10.1002/pu.31142","url":null,"abstract":"<p>A comparative effectiveness study using a U.S. commercial insurance database has found small increases in risk of mortality and other adverse outcomes when benzodiazepine treatment is discontinued in long-term users. Mortality risk was higher in subgroups of discontinuers both with and without exposure to opioids.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140031909","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Trial of zuranolone for depression finds mild to moderate adverse effects","authors":"","doi":"10.1002/pu.31144","DOIUrl":"https://doi.org/10.1002/pu.31144","url":null,"abstract":"","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140031911","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}